Billings P, Burakoff S, Dorf M E, Benacerraf B
J Exp Med. 1977 May 1;145(5):1387-92. doi: 10.1084/jem.145.5.1387.
Gene products coded for by the major hisocompatibility complex (MHC) can serve as target antigens for cytotoxic T lymphocytes (CTL) (1). A variety of test systems are available which have yielded information consistently reinforcing the importance of this complex of genes in the generation and effector phases of the cytotoxic immune response. Originally, it was shown that allogeneically-induced CTL had specificity primarily for the products of the K and D loci of the mouse H-2 complex (2). More recently this has also been found to be the case for xenogeneic immunizations (3,4). Additional examples of T cell-mediated lysis have been reported involving viral-infected or chemically- modified syngeneic stimulating and target cells in which homology at H-2K or H-2D was required between the responding and target cells for appreciable lysis to occur (5-7). Moreover, CTL specific for minor histocompatability antigens are able to lyse only target cells bearing these membrane antigens and sharing a common H-2K or H2-D gene product with the effector (8,9). Two hypotheses have been proposed to explain the requirement for H-2 identity between effector and targets in these systems. CTL may recognize new antigenic determinants created by the interaction of the modifier with syngeneic K and D gene products. Alternately, a dual recognition system my exist, requiring an antigen-specific receptor as well as a second receptor with specificity for homologous H-2K or H-2D determinants (5). Neither model can be excluded at this time. The I region also contains genes coding for histocompatibility loci since animals differing at the I-A or I-C regions of the H-2 complex reject skin grafts (10-12), though less rapidly than mice differing at the H-2K or H-2D regions, Also CTL can be generated to I region determinants but less efficiently than CTL specific for H-2K or H-2D gene products (12-14). The question can therefore be raised, whether the I region minor histocompatibility loci function independently from the H-2K or H-2D loci or whether I region-specific cytolysis requires the participation of H-2K or H-2D gene products of the target cell. This communication illustrates the generation of CTL showing specificity for I region determinants in primary mixed lymphocyte cultures. Further, we demonstrate by genetic analysis and byt eh use of speficit alloantisera that CTL directed to Ia determinants (a) do not see these antigens as modifications of H-2K or H-2D gene products but as independent gene products coded for by the I region, and (b) they do not require interaction with target cells bearing the same H-2K or H-2D gene product as the effect CTL.
主要组织相容性复合体(MHC)编码的基因产物可作为细胞毒性T淋巴细胞(CTL)的靶抗原(1)。有多种测试系统,它们所提供的信息不断强化了这一基因复合体在细胞毒性免疫反应的产生和效应阶段的重要性。最初发现,同种异体诱导的CTL主要对小鼠H-2复合体K和D位点的产物具有特异性(2)。最近还发现异种免疫也是如此(3,4)。还报道了其他T细胞介导的细胞裂解实例,涉及病毒感染或化学修饰的同基因刺激细胞和靶细胞,其中反应细胞和靶细胞之间在H-2K或H-2D处具有同源性才能发生明显的裂解(5-7)。此外,针对次要组织相容性抗原的CTL只能裂解携带这些膜抗原并与效应细胞共享共同H-2K或H2-D基因产物的靶细胞(8,9)。已提出两种假说来解释这些系统中效应细胞和靶细胞之间对H-2同一性的要求。CTL可能识别修饰剂与同基因K和D基因产物相互作用产生的新抗原决定簇。或者,可能存在一种双重识别系统,需要抗原特异性受体以及对同源H-2K或H-2D决定簇具有特异性的第二种受体(5)。目前这两种模型都不能排除。I区也包含编码组织相容性位点的基因,因为在H-2复合体的I-A或I-C区存在差异的动物会排斥皮肤移植(10-12),尽管比在H-2K或H-2D区存在差异的小鼠排斥速度要慢。此外,可以产生针对I区决定簇的CTL,但效率低于针对H-2K或H-2D基因产物的CTL(12-14)。因此可以提出这样一个问题,即I区次要组织相容性位点是否独立于H-2K或H-2D位点发挥作用,或者I区特异性细胞溶解是否需要靶细胞的H-2K或H-2D基因产物的参与。本通讯阐述了在初次混合淋巴细胞培养物中产生对I区决定簇具有特异性的CTL。此外,我们通过遗传分析和使用特异性同种异体抗血清证明,针对Ia决定簇的CTL(a)并不将这些抗原视为H-2K或H-2D基因产物的修饰,而是视为由I区编码的独立基因产物,并且(b)它们不需要与携带与效应CTL相同的H-2K或H-2D基因产物的靶细胞相互作用。